# The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain

> **NCT01185470** · PHASE2,PHASE3 · COMPLETED · sponsor: **Medallion Therapeutics, Inc.** · enrollment: 75 (actual)

## Conditions studied

- Cancers
- Chronic Pain

## Interventions

- **DEVICE:** Implantation of Morphine Sulfate delivering programmable pump

## Key facts

- **NCT ID:** NCT01185470
- **Lead sponsor:** Medallion Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2015-01
- **Final completion:** 2016-07
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2017-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01185470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01185470, "The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01185470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*